{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:45Z","timestamp":1792785045587,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of Taizhou Science and Technology Bureau in Zhejiang Prov-ince","award":["20ywa39"],"award-info":[{"award-number":["20ywa39"]}],"id":[{"id":"https:\/\/ror.org\/041fzeq08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H080001"],"award-info":[{"award-number":["LQ21H080001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58665-x","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:30Z","timestamp":1783149510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-cancer profiling of CDH2 and a GSK3\u03b2-sensitive anti-proliferative effect in K562 chronic myeloid leukemia cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Yingying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8564-3746","authenticated-orcid":false,"given":"Ruyi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"58665_CR1","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/j.humpath.2013.07.003","volume":"44","author":"Y Choi","year":"2013","unstructured":"Choi, Y. et al. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. Hum. Pathol. 44, 2581\u20132589. https:\/\/doi.org\/10.1016\/j.humpath.2013.07.003 (2013).","journal-title":"Hum. Pathol."},{"key":"58665_CR2","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/1078-0432.Ccr-05-2387","volume":"12","author":"I Lascombe","year":"2006","unstructured":"Lascombe, I. et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin. Cancer Res. 12, 2780\u20132787. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-05-2387 (2006).","journal-title":"Clin. cancer research: official J. Am. Association Cancer Res."},{"key":"58665_CR3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1365-2133.2012.10824.x","volume":"166","author":"L Hao","year":"2012","unstructured":"Hao, L., Ha, J. R., Kuzel, P., Garcia, E. & Persad, S. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K\/PTEN pathway through Twist and Snail. Br. J. Dermatol. 166, 1184\u20131197. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10824.x (2012).","journal-title":"Br. J. Dermatol."},{"key":"58665_CR4","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1038\/onc.2017.171","volume":"36","author":"Y Klymenko","year":"2017","unstructured":"Klymenko, Y. et al. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis. Oncogene 36, 5840\u20135851. https:\/\/doi.org\/10.1038\/onc.2017.171 (2017).","journal-title":"Oncogene"},{"key":"58665_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1083\/jcb.148.4.779","volume":"148","author":"RB Hazan","year":"2000","unstructured":"Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L. & Aaronson, S. A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148, 779\u2013790. https:\/\/doi.org\/10.1083\/jcb.148.4.779 (2000).","journal-title":"J. Cell Biol."},{"key":"58665_CR6","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","volume":"121","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-\u03b2-catenin signaling. Blood 121, 1824\u20131838. https:\/\/doi.org\/10.1182\/blood-2012-02-412890 (2013).","journal-title":"Blood"},{"key":"58665_CR7","doi-asserted-by":"publisher","unstructured":"Duffy, K. M. Innovations in the management of leukemia: role of biologic therapies. Cancer Nursing 26, 26s-31s, https:\/\/doi.org\/10.1097\/00002820-200312001-00007 (2003).","DOI":"10.1097\/00002820-200312001-00007"},{"key":"58665_CR8","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quint\u00e1s-Cardama","year":"2009","unstructured":"Quint\u00e1s-Cardama, A. & Cortes, J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113, 1619\u20131630. https:\/\/doi.org\/10.1182\/blood-2008-03-144790 (2009).","journal-title":"Blood"},{"key":"58665_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/jcb.22362","volume":"108","author":"CC Lin","year":"2009","unstructured":"Lin, C. C. et al. GSKIP, an inhibitor of GSK3beta, mediates the N-cadherin\/beta-catenin pool in the differentiation of SH-SY5Y cells. J. Cell. Biochem. 108, 1325\u20131336. https:\/\/doi.org\/10.1002\/jcb.22362 (2009).","journal-title":"J. Cell. Biochem."},{"key":"58665_CR10","first-page":"1274","volume":"5","author":"U Cavallaro","year":"2004","unstructured":"Cavallaro, U. N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr. Opin. Invest. drugs (London England: 2000). 5, 1274\u20131278 (2004).","journal-title":"Curr. Opin. Invest. drugs (London England: 2000)"},{"key":"58665_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.0303-6987.2004.0106.x","volume":"31","author":"S Krengel","year":"2004","unstructured":"Krengel, S., Grotel\u00fcschen, F., Bartsch, S. & Tronnier, M. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. J. Cutan. Pathol. 31, 1\u20137. https:\/\/doi.org\/10.1046\/j.0303-6987.2004.0106.x (2004).","journal-title":"J. Cutan. Pathol."},{"key":"58665_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1476-4598-11-61","volume":"11","author":"Z Peng","year":"2012","unstructured":"Peng, Z. et al. Dichotomy effects of Akt signaling in breast cancer. Mol. Cancer. 11, 61. https:\/\/doi.org\/10.1186\/1476-4598-11-61 (2012).","journal-title":"Mol. Cancer"},{"key":"58665_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 35, 314\u2013316. https:\/\/doi.org\/10.1038\/nbt.3772 (2017).","journal-title":"Nat. Biotechnol."},{"key":"58665_CR14","doi-asserted-by":"publisher","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14 https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","DOI":"10.1186\/1471-2105-14-7"},{"key":"58665_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003 (2013).","journal-title":"Immunity"},{"key":"58665_CR16","doi-asserted-by":"publisher","first-page":"153050","DOI":"10.1016\/j.tox.2021.153050","volume":"465","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Iron overload inhibits cell proliferation and promotes autophagy via PARP1\/SIRT1 signaling in endometriosis and adenomyosis. Toxicology 465, 153050. https:\/\/doi.org\/10.1016\/j.tox.2021.153050 (2022).","journal-title":"Toxicology"},{"key":"58665_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/07357900903476745","volume":"28","author":"K Li","year":"2010","unstructured":"Li, K., He, W., Lin, N., Wang, X. & Fan, Q. X. Downregulation of N-cadherin expression inhibits invasiveness, arrests cell cycle and induces cell apoptosis in esophageal squamous cell carcinoma. Cancer Invest. 28, 479\u2013486. https:\/\/doi.org\/10.3109\/07357900903476745 (2010).","journal-title":"Cancer Invest."},{"key":"58665_CR18","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/sj.bjc.6600955","volume":"88","author":"T Nakashima","year":"2003","unstructured":"Nakashima, T. et al. Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients. Br. J. Cancer. 88, 1727\u20131733. https:\/\/doi.org\/10.1038\/sj.bjc.6600955 (2003).","journal-title":"Br. J. Cancer"},{"key":"58665_CR19","first-page":"3819","volume":"61","author":"G Li","year":"2001","unstructured":"Li, G., Satyamoorthy, K. & Herlyn, M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 61, 3819\u20133825 (2001).","journal-title":"Cancer Res."},{"key":"58665_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3892\/ol.2022.13210","volume":"23","author":"CH Lu","year":"2022","unstructured":"Lu, C. H. et al. Small interfering RNA targeting N-cadherin regulates cell proliferation and migration in enzalutamide-resistant prostate cancer. Oncol. Lett. 23, 90. https:\/\/doi.org\/10.3892\/ol.2022.13210 (2022).","journal-title":"Oncol. Lett."},{"key":"58665_CR21","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1210\/en.2009-1489","volume":"151","author":"C Wang","year":"2010","unstructured":"Wang, C. & Roy, S. K. Expression of E-cadherin and N-cadherin in perinatal hamster ovary: possible involvement in primordial follicle formation and regulation by follicle-stimulating hormone. Endocrinology 151, 2319\u20132330. https:\/\/doi.org\/10.1210\/en.2009-1489 (2010).","journal-title":"Endocrinology"},{"key":"58665_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/bjs.8980","volume":"100","author":"S Saadatmand","year":"2013","unstructured":"Saadatmand, S. et al. Expression of cell adhesion molecules and prognosis in breast cancer. Br. J. Surg. 100, 252\u2013260. https:\/\/doi.org\/10.1002\/bjs.8980 (2013).","journal-title":"Br. J. Surg."},{"key":"58665_CR23","doi-asserted-by":"publisher","first-page":"165e111","DOI":"10.1016\/j.urolonc.2015.10.016","volume":"34","author":"A Drivalos","year":"2016","unstructured":"Drivalos, A. et al. Expression of \u03b15-integrin, \u03b17-integrin, \u0395-cadherin, and N-cadherin in localized prostate cancer. Urol. Oncol. 34, 165e111\u2013165e168. https:\/\/doi.org\/10.1016\/j.urolonc.2015.10.016 (2016).","journal-title":"Urol. Oncol."},{"key":"58665_CR24","doi-asserted-by":"publisher","first-page":"e62171","DOI":"10.1371\/journal.pone.0062171","volume":"8","author":"L Hui","year":"2013","unstructured":"Hui, L. et al. Prognostic significance of twist and N-cadherin expression in NSCLC. PloS one. 8, e62171. https:\/\/doi.org\/10.1371\/journal.pone.0062171 (2013).","journal-title":"PloS one"},{"key":"58665_CR25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1440-1746.2007.05182.x","volume":"23","author":"DD Seo","year":"2008","unstructured":"Seo, D. D. et al. Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients. J. Gastroenterol. Hepatol. 23, 1112\u20131118. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05182.x (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"58665_CR26","doi-asserted-by":"publisher","first-page":"1443e1447","DOI":"10.1016\/j.urology.2011.07.1388","volume":"78","author":"M Muramaki","year":"2011","unstructured":"Muramaki, M., Miyake, H., Terakawa, T., Kusuda, Y. & Fujisawa, M. Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy. Urology 78, 1443e1447\u20131443e1412. https:\/\/doi.org\/10.1016\/j.urology.2011.07.1388 (2011).","journal-title":"Urology"},{"key":"58665_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.urolonc.2017.01.012","volume":"35","author":"M Abufaraj","year":"2017","unstructured":"Abufaraj, M. et al. Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. Urol. Oncol. 35, 264\u2013271. https:\/\/doi.org\/10.1016\/j.urolonc.2017.01.012 (2017).","journal-title":"Urol. Oncol."},{"key":"58665_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1440-1827.2011.02774.x","volume":"62","author":"T Kamikihara","year":"2012","unstructured":"Kamikihara, T. et al. Clinical implications of N-cadherin expression in gastric cancer. Pathol. Int. 62, 161\u2013166. https:\/\/doi.org\/10.1111\/j.1440-1827.2011.02774.x (2012).","journal-title":"Pathol. Int."},{"key":"58665_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10585-006-9029-7","volume":"23","author":"L Derycke","year":"2006","unstructured":"Derycke, L. et al. Soluble N-cadherin fragment promotes angiogenesis. Clin. Exp. Metastasis. 23, 187\u2013201. https:\/\/doi.org\/10.1007\/s10585-006-9029-7 (2006).","journal-title":"Clin. Exp. Metastasis"},{"key":"58665_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1242\/jcs.087668","volume":"125","author":"E Camand","year":"2012","unstructured":"Camand, E., Peglion, F., Osmani, N., Sanson, M. & Etienne-Manneville N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration. J. Cell Sci. 125, 844\u2013857. https:\/\/doi.org\/10.1242\/jcs.087668 (2012).","journal-title":"J. Cell Sci."},{"key":"58665_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/b:neon.0000040811.14908.f2","volume":"70","author":"K Asano","year":"2004","unstructured":"Asano, K. et al. Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J. Neurooncol. 70, 3\u201315. https:\/\/doi.org\/10.1023\/b:neon.0000040811.14908.f2 (2004).","journal-title":"J. Neurooncol."},{"key":"58665_CR32","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.1073\/pnas.1606385113","volume":"113","author":"AV Cherian","year":"2016","unstructured":"Cherian, A. V., Fukuda, R., Augustine, S. M., Maischein, H. M. & Stainier, D. Y. N-cadherin relocalization during cardiac trabeculation. Proc. Natl. Acad. Sci. U.S.A. 113, 7569\u20137574. https:\/\/doi.org\/10.1073\/pnas.1606385113 (2016).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"58665_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3760\/cma.j.cn121090-20240130-00045","volume":"45","author":"FY Zheng","year":"2024","unstructured":"Zheng, F. Y. et al. [Research on the clinical characteristics and prognosis of children with chronic myeloid leukemia in the blast phase]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 45, 931\u2013936. https:\/\/doi.org\/10.3760\/cma.j.cn121090-20240130-00045 (2024).","journal-title":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi"},{"key":"58665_CR34","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3892\/ijo.2014.2549","volume":"45","author":"A Walker","year":"2014","unstructured":"Walker, A., Frei, R. & Lawson, K. R. The cytoplasmic domain of N-cadherin modulates MMP\u20139 induction in oral squamous carcinoma cells. Int. J. Oncol. 45, 1699\u20131706. https:\/\/doi.org\/10.3892\/ijo.2014.2549 (2014).","journal-title":"Int. J. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58665-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:45:31Z","timestamp":1791153931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58665-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58665"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58665-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (approval number: 2021-KL-099-01). The Institutional Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University waived the need for informed consent due to the retrospective use of de-identified residual samples, in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the article and approved the submitted version.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30733"}}